SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ANDRX (ADRX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (27)9/17/1997 12:50:00 PM
From: PAUL ROBERT ST. ONGE   of 127
 
Pleased to learn of the new target by Gruntal, and now that makes three strong buy's per analyst recommendations. Also a fourth exists
via Oppenheimer although is not tracked by Zack's I believe, but believe it is a buy or better recommendation. I am looking forward
to the next potential approval, Dilacor to start beefing up the revenue stream, and obviously turning the company profitable.
I remain confident my top three picks, Andrx, Nextel, and Wild Oats,
will continue to provide strong results through 1999.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News